Skip to main content
Clinical Trials/JPRN-jRCTs052190050
JPRN-jRCTs052190050
Completed
Phase 1

Research on the improvement effect of spasticity by extracorporeal shock wave

Kawabata Hidehiko0 sites77 target enrollmentSeptember 11, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Central neuropathy (cerebral palsy, cerebral hemorrhage, cerebral infarction, acute encephalopathy s
Sponsor
Kawabata Hidehiko
Enrollment
77
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

We examined the effectiveness of extracorporeal shock wave treatment for upper and lower limb spasticity associated with central neuropathy. The ankle dorsal flexion angle was improved by irradiation of the gastrocnemius muscle. Regarding the knee joint and upper limb, it was difficult to carry out the planned research due to the epidemic of COVID-19.

Registry
who.int
Start Date
September 11, 2019
End Date
December 21, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kawabata Hidehiko

Eligibility Criteria

Inclusion Criteria

  • 1\. Central nervous disorder with spasticity in upper and lower extremity muscles
  • 2\. Orthopedic surgery, botulinum therapy, baclofen intrathecal treatment not received within the past 6 months
  • 3\. Written informed consent has been obtained from the person or the principal regarding participation in this examination

Exclusion Criteria

  • 1\. Oral administration of anticoagulant
  • 2\. Patients with thrombosis, patients with malignancy
  • Patients who have been receiving cortisone treatment for 3\.6 months or more or who have not been 6 weeks since the last cortisone injection
  • 4\. May be pregnant or pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials